IS NEPHRECTOMY JUSTIFIED IN PATIENTS WITH METASTATIC RENAL CARCINOMA

被引：139
|
作者：
JOHNSON, DE
KAESLER, KE
SAMUELS, ML
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CANC CTR,DEPT MED,HOUSTON,TX 77025
[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CANC CTR,DEPT SURG,SECT UROL,HOUSTON,TX 77025
来源：
JOURNAL OF UROLOGY | 1975年 / 114卷 / 01期
关键词：
D O I：
10.1016/S0022-5347(17)66934-9
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：27 / 29
页数：3
相关论文
共 50 条
  • [41] Sunitinib and Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Bajic, Petar
    Flanigan, Robert C.
    Joyce, Cara J.
    Clark, Joseph I.
    JOURNAL OF UROLOGY, 2019, 201 (03): : 453 - 454
  • [42] Partial nephrectomy in the setting of metastatic renal cell carcinoma
    Babaian, Kara
    Matin, Surena F.
    Tamboli, Pheroze
    Tannir, Nizar M.
    Jonasch, Eric
    Wood, Christopher G.
    Karam, Jose A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [43] Partial Nephrectomy in the Setting of Metastatic Renal Cell Carcinoma
    Babaian, Kara N.
    Merrill, Megan M.
    Matin, Surena
    Tamboli, Pheroze
    Tannir, Nizar M.
    Jonasch, Eric
    Wood, Christopher G.
    Karam, Jose A.
    JOURNAL OF UROLOGY, 2014, 192 (01): : 36 - 42
  • [44] Back to nephrectomy for patients with metastatic renal cancer
    Klotz, L
    LANCET, 2001, 358 (9286): : 948 - 949
  • [45] Results of nephrectomy for patients with metastatic renal cancer
    Russo, P
    Saranchuk, J
    Touijer, K
    Snyder, ME
    Drucker, B
    Motzer, R
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S101 - S101
  • [46] Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma
    Fallick, ML
    McDermott, DF
    LaRock, D
    Long, JP
    Atkins, MB
    JOURNAL OF UROLOGY, 1997, 158 (05): : 1691 - 1695
  • [47] Time to change paradigm - no need for initial nephrectomy in patients with metastatic renal cell carcinoma?
    Kawecki, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (04): : 238 - 239
  • [48] NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
    Liu, Huanrui
    Li, Senlin
    Zhang, Fan
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    BIOMARKERS IN MEDICINE, 2025,
  • [49] IDENTIFYING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA WHO WILL NOT BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY
    Culp, Stephen H.
    Abel, E. Jason
    Margulis, Vitaly
    Bill, Kate Lynn
    Tamboli, Pheroze
    Jonasch, Eric
    Matin, Surena F.
    Swanson, David A.
    Tannir, Nizar M.
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 498 - 498
  • [50] Nephrectomy status, race, and overall survival in patients with metastatic renal cell carcinoma.
    Robertson, Dale Kesley
    Zhang, Chao
    Liu, Yuan
    Gillespie, Theresa Wicklin
    Kucuk, Omer
    Carthon, Bradley Curtis
    Master, Viraj A.
    Issa, Muta
    Petros, John
    Harris, Wayne B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345